Skip to main content
# Title Department Research Year
111 Regiodivergent biosynthesis of bridged bicyclononanes Department of Pharmacognosy 2024
112 Development of Oral Formulation of Lepidium Seeds Significantly Decreases the High Blood Glucose Levels in Diabetic Rats; In Vitro Formulation and In Vivo Antidiabetic Performance. Department of Industrial Pharmacy 2024
113 Zirconium-based hydrophobic-MOFs as innovative electrode modifiers for flibanserin determination: Exploring the electrooxidation mechanism using a comprehensive spectroelectrochemical study Department of Pharmaceutical Analytical Chemistry 2024
114 Synthesis, enzyme inhibition, and docking studies of new Schiff bases of disalicylic acid methylene-based derivatives as dual-target antibacterial agents Department of Pharmaceutical Organic Chemistry 2024
115 Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit incidence, types, and acceptability Department of Clinical Pharmacy 2024
116 Dual emission BSA-capped bimetallic nanoclusters for detection of acrylamide in certain food matrices based on thiol-ene Michael addition click reaction Department of Pharmaceutical Analytical Chemistry 2024
117 Developing a switch “OFF-ON” fluorescent probe for detection of melamine based on doubly-protected red emissive copper nanoclusters mediated by Hg2+ ions Department of Pharmaceutical Analytical Chemistry 2024
118 Finding new analgesics: Computational pharmacology faces drug discovery challenges Department of Pharmacology 2024
119 Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and Topoisomerase IV inhibitors endowed with antibacterial properties Department of Pharmaceutical Organic Chemistry 2024
120 Copper @ eggshell nanocomposite/chitosan gelified carbon paste electrode as an electrochemical biosensor for l-tyrosine analysis as a biomarker in the serum of normal and liver disease patients Department of Pharmaceutical Analytical Chemistry 2024